Why the study?
Tuberculosis of the myocardium is extremely rare, diagnosis is often delayed, and outcomes are unfavorable, particularly when cardiac involvement is the presenting entity.
Does antitubercular therapy combined with supportive antiarrhythmic measures improve outcomes in patients with myocardial tuberculosis presenting as life-threatening ventricular arrhythmia?
Does antitubercular therapy combined with supportive antiarrhythmic measures improve outcomes in patients with myocardial tuberculosis presenting as life-threatening ventricular arrhythmia?
Myocardial tuberculosis is a rare but definite clinical entity that can present as life-threatening ventricular arrhythmia and is successfully treatable with early antitubercular and antiarrhythmic therapy.
May support antitubercular therapy in myocardial TB with ventricular arrhythmias; hypothesis-generating case series requiring prospective validation.
BACKGROUND: Tuberculosis of the myocardium is an extremely rare entity with few published case reports. Diagnosis is often delayed, and outcomes are unfavorable: particularly when cardiac involvement has been the presenting entity. METHODS: Four patients, aged 24-51 years, presented with life-threatening ventricular arrhythmia (VA). None had a previous history of tuberculosis or any structural heart disease. Electrocardiogram during sinus rhythm and Echocardiography did not show any gross abnormality. All patients underwent contrast-enhanced computer tomography of thorax and cardiac magnetic resonance imaging. Attempts to obtain tissue (cardiac or associated mediastinal lymph nodes) were associated with increased risk to the patients thus indirect evidence of Mantoux skin test and interferon gamma release assay results were used to aid diagnosis. RESULTS: Based on clinicoradiological findings, patients were put on antitubercular therapy (ATT). Supportive therapy included antiarrhythmic drugs (all patients), catheter ablation (two patients), and implantable cardioverter defibrillator (one patient). Arrhythmia suppression was achieved in all patients predischarge. On a follow-up of 2-24 months, none of the patients has had any recurrence of arrhythmia. ATT and antiarrhythmic drug therapy have been stopped in two patients who have completed the 6 months of ATT. Their radiological lesions showed resolution. CONCLUSIONS: Myocardial tuberculosis presenting as life-threatening VA in a rare but definite clinical entity. A high index of suspicion and cardiac imaging can lead to early diagnosis and appropriate treatment that ensures survival in all patients.
No takes yet. Share an insight, caveat, or question.
Nair et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: